SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERLINI, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.166
EU - Europa 5.232
AS - Asia 2.962
SA - Sud America 37
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
AF - Africa 6
Totale 27.426
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.131
CN - Cina 1.488
UA - Ucraina 1.073
IT - Italia 1.018
PL - Polonia 938
DE - Germania 823
SG - Singapore 648
TR - Turchia 598
GB - Regno Unito 525
SE - Svezia 326
FI - Finlandia 263
ID - Indonesia 109
FR - Francia 56
BE - Belgio 46
RU - Federazione Russa 43
CZ - Repubblica Ceca 41
VN - Vietnam 37
CA - Canada 27
BR - Brasile 23
IN - India 20
NL - Olanda 20
IR - Iran 16
LK - Sri Lanka 16
ES - Italia 13
EU - Europa 12
AT - Austria 9
AU - Australia 9
RO - Romania 8
CH - Svizzera 7
EC - Ecuador 6
KR - Corea 6
CO - Colombia 5
JP - Giappone 5
DZ - Algeria 4
MX - Messico 4
MY - Malesia 4
GR - Grecia 3
SA - Arabia Saudita 3
SI - Slovenia 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PR - Porto Rico 2
VA - Santa Sede (Città del Vaticano) 2
CY - Cipro 1
GT - Guatemala 1
HK - Hong Kong 1
HR - Croazia 1
IE - Irlanda 1
JO - Giordania 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 27.426
Salva come PNG Salva come JPEG
Città #
Fairfield 2.906
Woodbridge 2.359
Houston 1.602
Chandler 1.434
Ashburn 1.296
Jacksonville 1.258
Ann Arbor 1.224
Seattle 1.087
Wilmington 968
Cambridge 951
Warsaw 937
Singapore 467
Izmir 387
Nanjing 338
Beijing 333
Princeton 297
Boardman 216
San Diego 211
Ferrara 203
New York 160
Shanghai 153
Milan 140
Bremen 121
Jakarta 107
Shenyang 94
Dearborn 86
Munich 85
Los Angeles 80
Nanchang 79
Hebei 76
Falls Church 74
Santa Clara 71
Tianjin 71
Redwood City 67
Changsha 56
Rome 54
San Mateo 51
London 45
Jiaxing 43
Bologna 42
Mountain View 42
Brussels 38
Norwalk 38
Helsinki 35
Dong Ket 34
Jinan 34
Brno 33
Kunming 33
Orange 30
Washington 28
Zhengzhou 23
Addison 22
Auburn Hills 22
Ningbo 21
Tappahannock 20
Des Moines 18
Guangzhou 17
Taizhou 17
Lanzhou 16
Philadelphia 16
Kilburn 15
Verona 15
Indiana 13
Redmond 13
Padova 12
Pisa 11
Walnut 11
Augusta 10
Hangzhou 10
Monmouth Junction 10
Chicago 9
Haikou 9
Hefei 9
Leawood 9
Phoenix 9
Toronto 9
Ardabil 8
Florence 8
Hounslow 8
Naples 8
Chiswick 7
Pieve Di Cadore 7
Trebaseleghe 7
Turin 7
Lappeenranta 6
Montréal 6
Napoli 6
Pavia 6
Reggio Emilia 6
Reggio Nell'emilia 6
Changchun 5
Ferrara di Monte Baldo 5
Jesi 5
Malvern East 5
Osasco 5
Quito 5
San Francisco 5
Siena 5
Acton 4
Brescia 4
Totale 21.084
Salva come PNG Salva come JPEG
Nome #
Deep RNA profiling identified CLOCK and molecular clock genes as pathophysiological signatures in collagen VI myopathy 328
POPDC1S201F causes muscular dystrophy and arrhythmia by affecting protein trafficking 304
Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression 299
Oligonucleotidi antisenso atti ad indurre lo skipping esonico e loro impiego come medicamento per il trattamento della distrofia muscolare di Duchenne (DMD) 292
Antisense Oligonucleotide-Based Therapy for Neuromuscular Disease 219
Persistent Dystrophin Protein Restoration 90 Days after a Course of Intraperitoneally Administered Naked 2′OMePS AON and ZM2 NP-AON Complexes in mdx Mice 195
Duchenne muscular dystrophy: From diagnosis to therapy 186
Trisomy 15 mosaicism owing to familial reciprocal translocation t(1;15): implication for prenatal diagnosis. 179
Urinary Stem Cells as Tools to Study Genetic Disease: Overview of the Literature 159
A multicenter comparison of quantification methods for antisense oligonucleotide-induced DMD exon 51 skipping in Duchenne muscular dystrophy cell cultures 153
Omics approach and novel biostatistic tools identified RPL3L as potential genetic modifier of clinical severity in female carriers of Duchenne muscle dystrophy 151
Occurrence of del(GIB6-D13S1830) mutation in Italian non-syndromic hearing loss patients carrying a single GJB2 mutated allele. 150
Haplotype analysis of common transthyretin mutations 150
The medical genetics of dystrophinopathies: Molecular genetic diagnosis and its impact on clinical practice 149
Transcriptomics analysis in collagen VI myopathy: Role of circadian genes using novel fluidic card tools 148
Duchenne Muscular Dystrophy Myogenic Cells from Urine-Derived Stem Cells Recapitulate the Dystrophin Genotype and Phenotype 147
Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype 145
Macrophages: a minimally invasive tool for monitoring collagen VI myopathies 143
Exon skipping-mediated dystrophin reading frame restoration for small mutations 141
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse 141
Paternal germline mosaicism in collagen VI related myopathies 137
Atypical familial motor neuropathy in patients with mutant TTR Ile68Leu 136
A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy 134
Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point. 133
Antisense-Induced Messenger Depletion Corrects a COL6A2 Dominant Mutation in Ullrich Myopathy 132
null 131
Gender-related risk of myocardial involvement in systemic amyloidosis 130
The absence of dystrophin brain isoform expression in healthy human heart ventricles explains the pathogenesis of 5 ' X-linked dilated cardiomyopathy 130
Biochemical characterization of patients with in-frame or out-of-frame DMD deletions pertinent to exon 44 or 45 skipping. 130
Exon Skipping Quantification by Real-Time PCR 129
Validation of genetic modifiers for Duchenne muscular dystrophy: a multicentre study assessing SPP1 and LTBP4 variants 129
Audiological profiles and gjb2, gjb6 mutations: A retrospective study on genetic and clinical data from 2003 to 2008 127
Dystrophin quantification and clinical correlations in Becker muscular dystrophy: Implications for clinical trials 127
The DMD Locus Harbours Multiple Long Non-Coding RNAs Which Orchestrate and Control Transcription of Muscle Dystrophin mRNA Isoforms 127
Characterization of a deleted Y chromosome in a male with Turner stigmata 127
Mitochondrial dysfunction in the pathogenesis of Ullrich congenital muscular dystrophy and prospective therapy with cyclosporins 126
Identification of a deep intronic mutation in the COL6A2 gene by a novel custom oligonucleotide CGH array designed to explore allelic and genetic heterogeneity in collagen VI-related myopathies 126
Autosomal recessive myosclerosis myopathy is a collagen VI disorder 124
Defining the Diagnosis in Echocardiographically Suspected Senile Systemic Amyloidosis 124
Genomic definition of a pure intronic dystrophin deletion responsible for an XLDC splicing mutation: In vitro mimicking and antisense modulation of the splicing abnormality 123
Prevalence of congenital muscular dystrophy in Italy: a population study 123
Nonhomologous Robertsonian translocations (NHRTs) and uniparental disomy (UPD) risk: an Italian multicentric prenatal survey. 122
null 121
Double Interstitial Deletion of the Long Arm of Chromosome 6 in a Patient with Pierre Robin Sequence, Dysmorphisms, and Severe Developmental Delay 121
A novel custom high density-comparative genomic hybridization array detects common rearrangements as well as deep intronic mutations in dystrophinopathies 119
A comprehensive genomic approach for neuromuscular diseases gives a high diagnostic yield 119
Mutation Load of Multiple Ion Channel Gene Mutations in Brugada Syndrome 119
Pura syndrome: an emerging neurodevelopmental disorder 119
Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies 118
Cyclosporine a in Ullrich congenital muscular dystrophy: Long-term results 118
X-linked bulbar and spinal muscular atrophy, or Kennedy disease: clinical, neurophysiological, neuropathological, neuropsychological and molecular study of a large family. 118
D.P.12 Whole exome sequencing and RNAseq in a Duchenne-like female with no dystrophin mutations: Search for dystrophin gene modifiers 118
Androgen receptor gene (CAG)n repeat analysis in the differential diagnosis between Kennedy disease and other motoneuron disorders. 117
X-linked dilated cardiomyopathy and the dystrophin gene. 116
Biomarkers and surrogate endpoints in Duchenne: meeting report 116
Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array 116
Role of 99mTc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis 116
A current approach to heart failure in Duchenne muscular dystrophy 116
Attention Deficit Hyperactivity Disorder and Cognitive Function in Duchenne Muscular Dystrophy: Phenotype-Genotype Correlation 116
Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females. 115
D.P.9 Whole exome sequencing filtered by novel candidate genes as tool for gene discovery in a recessive family with Parkinson and ataxia 115
Identical de novo mutation at the D4F104S1 locus in monozygotic male twins affected by facioscapulohumeral muscular dystrophy (FSHD) with different clinical expression. 114
Melanocytes--a novel tool to study mitochondrial dysfunction in Duchenne muscular dystrophy 114
Tempo and mode of evolution of a primate-specific retrotransposon belonging to the LINE 1 family. 114
GENETIC, CLINICAL AND NEUROPATHOLOGICAL INSIGHTS INTO PATIENTS WITH ASCERTAINED DIAGNOSIS OF HUNTINGTON DISEASE 114
Characterization of a rare case of Ullrich congenital muscular dystrophy due to truncating mutations within the COL6A1 gene C-terminal domain: a case report 114
null 113
Preclinical PK and PD studies on 2′-O-methyl-phosphorothioate RNA antisense oligonucleotides in the mdx mouse model 113
Thyroid function in Rett syndrome 113
null 113
Intronic breakpoint definition and transcription analysis in DMD/BMD patients with deletion/duplication at the 5′ mutation hot spot of the dystrophin gene 113
Early corticosteroid treatment in 4 duchenne muscular dystrophy patients: 14-year follow-up 112
Is there selection in favour of heterozygotes in families with merosin-deficient congenital muscular dystrophy? 112
G.P.12.06 A comprehensive molecular characterisation of dystrophinopathies 112
Investigating the mechanism of chromosomal deletion: Characterization of 39 deletion breakpoints in introns 47 and 48 of the human dystrophin gene 111
Autosomal recessive Bethlem myopathy 111
Dystrophin gene abnormalities in two patients with idiopathic dilated cardiomyopathy 111
SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers. 111
Biomarkers in rare neuromuscular diseases. 111
Characterization of Hb Calvino (HBB: c.406G > A): A New Silent β-Globin Gene Variant Found in Coexistence with α-Thalassemia in a Family of African Origin 111
Diagnostic Work-Up and Risk Stratification in X-Linked Dilated Cardiomyopathies Caused by Dystrophin Defects 110
Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy 110
Defective collagen VI α6 chain expression in the skeletal muscle of patients with collagen VI-related myopathies. 110
Transcriptional behavior of DMD gene duplications in DMD/BMD males 110
A Clinical Case of Catecholaminergic Polymorphic Ventricular Tachycardia: The Clinical Suspicious and the Need of Genetics 110
Prenatal genetic counseling referrals for advanced maternal age: still room for improvement. 109
Genetic counseling for women referred for advanced maternal age: a telegenetic approach 109
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective 109
Mutation and transcription analysis of transthyretin gene in Italian families with hereditary amyloidosis: A putative novel 'hot spot' in codon 47 108
Prenatal diagnosis of a complete mole coexisting with a dichorionic twin pregnancy: case report. 108
Coexistent central and peripheral nervous system involvement in a Charcot-Marie-Tooth syndrome X-linked patient 108
G.P.15 Whole transcriptome expression profiling in COL6a1 null mice shows deregulation of circadian clock genes as exploratory COL6 myopathies biomarkers 108
Dystrophin and mutations: One gene, several proteins, multiple phenotypes 108
A Family with γ-Thalassemia and High Hb A2 Levels 108
In vivo study of an aberrant dystrophin exon inclusion in X-linked dilated cardiomyopathy. 107
Transthyretin amyloidosis and superficial siderosis of the CNS 107
Molecular strategies in genetic diagnosis of transthyretin-related hereditary amyloidosis. 107
A patient with limb girdle muscular dystrophy carries a TRIM32 deletion, detected by a novel CGH array, in compound heterozygosis with a nonsense mutation 107
D.P.7 Whole exome sequencing as genetic diagnostic tool in myofibrillar myopathies 107
Commercial kit-based diagnosis is not enough for prenatal testing of beta-thalassemia: pitfalls in diagnostic mutation analysis raises the need for reference laboratories 107
Totale 13.143
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.202
Totale 129.556
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.340 0 0 0 1.016 514 794 662 708 576 588 317 165
2020/20214.273 344 399 232 495 220 443 169 500 151 538 532 250
2021/20223.180 159 267 270 113 165 147 202 174 138 242 324 979
2022/20233.263 332 265 72 416 587 442 113 303 403 37 175 118
2023/20241.735 167 223 114 44 122 276 58 96 62 52 54 467
2024/2025956 183 140 579 54 0 0 0 0 0 0 0 0
Totale 27.924